StubHub shares plummeted 35% in March following a disappointing earnings report. The company's second earnings report showed revenue declines and missed analyst expectations. Challenges included a lack of major events like Taylor Swift tours and the industry's shift to 'all-in' ticket pricing.
ImmunityBio's stock price experienced a significant decline on Monday following a warning letter from the U.S. Food and Drug Administration (FDA). The regulatory body flagged promotional materials for the company's drug, Anktiva, specifically citing a TV advertisement and a podcast episode. According to the FDA, these…
Read the full storyLennar Corporation (LEN) shares experienced a significant decline of 24.1% throughout the month of March. The sharp sell-off was triggered by the release of a disappointing quarterly earnings report that fell short of market expectations. A key factor in the decline was a notable year-over-year drop in the average…
StubHub shares experienced a significant 35% decline throughout March after the company released a disappointing quarterly earnings report. The financial results, marking only the company's second report since going public, revealed a decline in revenue that missed analyst expectations. Management attributed the weak…